Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tacalcitol cream effectively and safely treated a rare skin condition called Lichen Spinulosus in two cases.

Botulinum toxin injections effectively relieve pain from cutaneous leiomyomas.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

LPA 4 helps control blood and lymph vessel development in zebrafish.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Cathelicidins could treat skin issues but face challenges like safety and resistance.

Finasteride increases CD8+ T cells in BPH tissues.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib may help regrow hair in alopecia areata patients.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.